y 27632 has been researched along with jnj 10198409 in 2 studies
| Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (jnj 10198409) | Trials (jnj 10198409) | Recent Studies (post-2010) (jnj 10198409) |
|---|---|---|---|---|---|
| 1,924 | 3 | 891 | 6 | 0 | 4 |
| Protein | Taxonomy | y 27632 (IC50) | jnj 10198409 (IC50) |
|---|---|---|---|
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | 0.022 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 0.1 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 0.378 | |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | 0.0038 | |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | 0.185 | |
| Platelet-derived growth factor receptor alpha | Homo sapiens (human) | 0.045 | |
| Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 3.1 | |
| Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | 3.1 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 3.1 | |
| Casein kinase I isoform alpha | Homo sapiens (human) | 7.2 | |
| Casein kinase I isoform delta | Homo sapiens (human) | 7.2 | |
| Casein kinase I isoform epsilon | Homo sapiens (human) | 7.2 | |
| Casein kinase I isoform gamma-2 | Homo sapiens (human) | 7.2 | |
| Casein kinase I isoform gamma-1 | Homo sapiens (human) | 7.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
| Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A | 1 |
2 other study(ies) available for y 27632 and jnj 10198409
| Article | Year |
|---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase | 2013 |